Abstract
Plasma NfL (pNfL) levels are elevated in many neurological disorders. However, the utility of pNfL in a clinical setting has not been established. In a cohort of diverse older participants, we examined: 1) the association of pNfL to age, sex, Hispanic ethnicity, diagnosis, and structural and amyloid imaging biomarkers; and 2) its association to baseline and longitudinal cognitive and functional performance. 309 subjects were classified at baseline as cognitively normal (CN) or with cognitive impairment. Most subjects had structural MRI and amyloid PET scans. The most frequent etiological diagnosis was Alzheimer's disease (AD), but other neurological and neuropsychiatric disorders were also represented. We assessed the relationship of pNfL to cognitive and functional status, primary etiology, imaging biomarkers, and to cognitive and functional decline. pNfL increased with age, degree of hippocampal atrophy, and amyloid load, and was higher in females among CN subjects, but was not associated with Hispanic ethnicity. Compared to CN subjects, pNfL was elevated among those with AD or FTLD, but not those with neuropsychiatric or other disorders. Hippocampal atrophy, amyloid positivity and higher pNfL levels each added unique varianc...Continue Reading
References
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Nov 1, 1993·Neurology·J C Morris
Dec 18, 2001·Journal of Neuroscience Research·M SjögrenA Wallin
Nov 24, 2004·International Psychogeriatrics·Dylan G HarwoodRanjan Duara
Aug 24, 2005·Neurology·J A LuchsingerR Mayeux
Dec 10, 2008·Neurology·R DuaraH Potter
May 23, 2009·Brain : a Journal of Neurology·Rahul S DesikanUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jun 19, 2010·Archives of Neurology·Sid E O'BryantC Munro Cullum
Mar 23, 2011·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Ranjan DuaraHuntington Potter
Apr 26, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Guy M McKhannCreighton H Phelps
May 2, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·David A LoewensteinRanjan Duara
Oct 20, 2012·Lancet Neurology·Yaakov Stern
Jun 14, 2014·Neuropsychiatric Disease and Treatment·Mahesh N SamtaniVaibhav A Narayan
Oct 29, 2014·Acta Neuropathologica·John F CraryPeter T Nelson
Mar 6, 2015·Clinical and Translational Imaging : Reviews in Nuclear Medicine and Molecular Imaging·Osama SabriHenryk Barthel
Nov 3, 2015·JAMA Neurology·Henrik ZetterbergUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Oct 30, 2016·Neurobiology of Aging·Ane-Victoria IdlandAnders Martin Fjell
Mar 28, 2017·JAMA Neurology·Niklas MattssonUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jun 24, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Christopher C RoweVictor L Villemagne
Dec 16, 2017·Annals of Neurology·Patricia A BoyleDavid A Bennett
Apr 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackUNKNOWN Contributors
Jul 11, 2018·Frontiers in Aging Neuroscience·Isabelle BosPieter Jelle Visser
Jul 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michael NavitskyMichael D Devous
Sep 27, 2018·Journal of Neuroinflammation·Estella A NewcombeRodrigo Medeiros
Oct 31, 2018·Alzheimer Disease and Associated Disorders·Lilah BesserUNKNOWN Neuropsychology Work Group, Directors, and Clinical Core leaders of the National Institute on Aging-funded US Alzheimer’s Di
Apr 18, 2019·NeuroImage. Clinical·R DuaraDeKosky St
May 1, 2019·Brain : a Journal of Neurology·Peter T NelsonJulie A Schneider
Jun 18, 2019·JAMA Neurology·Claire BridelEdward J Wild
Jun 19, 2019·JAMA : the Journal of the American Medical Association·Clifford R JackRonald C Petersen
Oct 9, 2019·Journal of Neurology·Kasper KatiskoEino Solje
Oct 11, 2019·Neurology·Daniele AltomareWiesje M van der Flier
Nov 9, 2019·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Katie E OsbornAngela L Jefferson
Mar 25, 2020·Brain : a Journal of Neurology·Frank de WolfM Arfan Ikram